Drug interactions
Carbidopa-entacapone-levodopa + Dihydroergotamine intranasal
Severity: Minor
Carbidopa-entacapone-levodopa and Dihydroergotamine intranasal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both agents act on monoaminergic systems, and a serotonin-related interaction is suggested. Dihydroergotamine also causes vasoconstriction and can aggravate nausea or blood pressure changes, while levodopa can cause nausea and orthostatic hypotension. The clinical significance is uncertain and likely modest.
What this interaction means in plain words
Carbidopa-entacapone-levodopa and Dihydroergotamine intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Possible additive serotonergic and dopaminergic receptor effects; the mechanism is not firmly established.
What to do
Monitor for nausea, blood pressure changes and signs of serotonergic excess when dihydroergotamine is used. No dose change is usually needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carbidopa-entacapone-levodopa and Dihydroergotamine intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Carbidopa-entacapone-levodopa
- Carbidopa-entacapone-levodopa + Isocarboxazid Contraindicated
- Carbidopa-entacapone-levodopa + Phenelzine Contraindicated
- Carbidopa-entacapone-levodopa + Selegiline transdermal Contraindicated
- Carbidopa-entacapone-levodopa + Tranylcypromine Contraindicated
- Amisulpride + Carbidopa-entacapone-levodopa Major
- Asenapine transdermal + Carbidopa-entacapone-levodopa Major
Frequently asked questions
Can I take Carbidopa-entacapone-levodopa with Dihydroergotamine intranasal?
MediHelp rates the interaction as minor. Carbidopa-entacapone-levodopa and Dihydroergotamine intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Both agents act on monoaminergic systems, and a serotonin-related interaction is suggested. Dihydroergotamine also causes vasoconstriction and can aggravate nausea or blood pressure changes, while levodopa can cause nausea and orthostatic hypotension. The clinical significance is uncertain and likely modest.
How serious is the interaction between Carbidopa-entacapone-levodopa and Dihydroergotamine intranasal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for nausea, blood pressure changes and signs of serotonergic excess when dihydroergotamine is used. No dose change is usually needed.
What other medicines interact with Carbidopa-entacapone-levodopa?
MediHelp also lists interactions of Carbidopa-entacapone-levodopa with, for example, Isocarboxazid, Phenelzine, Selegiline transdermal. The full list is on the Carbidopa-entacapone-levodopa page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
